Advanced Practice Providers Oncology Summit.

ONCOLOGY 102 Virtual Conference

2026 Oncology 102 Virtual Conference

October 22nd - 24th

Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers

As the demand for cancer care continues to rise, the need for oncology specialists is outpacing workforce supply, creating a gap in care delivery. Advanced practice providers (APPs)—whose education emphasizes health promotion, disease prevention, and medical management—are playing an increasingly vital role in oncology teams. Many APPs entering the specialty, however, have limited formal training in hematology and oncology, making structured education essential.
Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers, developed by Horizon CME in partnership with APAO, is a two-and-a-half-day virtual program designed to expand clinical knowledge and practical skills across oncology care. Participants will explore advanced treatment strategies, supportive and palliative care, biomarker-guided therapies, disease-specific management, and patient-centered care approaches.

This program builds on foundational knowledge from Oncology 101, helping APPs strengthen their clinical confidence and enhance their ability to care for patients as integral members of multidisciplinary oncology teams.

Registration Details

Advanced Registration

$ 175
00
  •  
DEADLINE: SEPT 22

General Registration

$ 225
00
  •  
DEADLINE: OCT 22

Student/Fellows*

$ 50
00
  •  
DEADLINE: OCT 22
REGISTER HERE

In Partnership With:

*Students - Fellows

Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.

If you would like to attend as a Student, please contact info@horizoncme.com for further information.

**Industry Employee - See Registration Page for Pricing

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc). 

Learning Objectives

Learning Objectives

  1. Describe the presentation, evaluation, and treatment of common, solid, and hematologic malignancies
  2. Recognize the presentation, evaluation, and treatment of common benign hematologic disorders
  3. Summarize the role of genetics and molecular testing in cancer care
  4. Compare and contrast the various types of cancer treatment including stem cell transplant, chemotherapy, targeted therapies, radiotherapy, and immunotherapy
  5. Identify and appropriately manage common oncologic emergencies
  6. Outline the role of palliative care and effectively incorporate it into oncology practice

Intended Learners

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Planning Committee

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN

Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic Cleveland, OH

Beth Sandy, MSN, CRNP

Nurse Practitioner Abramson Cancer Center, University of Pennsylvania Philadelphia, PA

Danielle Roberts, PA-C

APP Education Lead Co-Director Hematology/Oncology APP Fellowship Winship Cancer Institute, Emory University Atlanta, GA

Leigh Ann Childress, MSN, NP, AOCNP

Director of Advanced Practice Clearview Cancer Institute Huntsville, AL

Val R. Adams, PharmD, FCCP, FHOPA, BCOP

Associate Professor, University of Kentucky Oncology Specialist Markey Cancer Center Lexington, KY